Skip to main content

Table 2 Comparison between group I (control group) and group II (case group) regarding complications occurred during the course of treatment

From: Effectiveness and safety of ombitasvir/paritaprevir/ritonavir in treatment of chronic hepatitis C Egyptian hemodialysis patients, case-control study

  Group I Group II Test valuea p value
No. % No. %
Patient stopped treatment 0 0.0 6 12.0 6.383 0.012
Death 0 0.0 3 6.0 3.093 0.079
Blood transfusion 0 0.0 5 10.0 5.263 0.022
Itching 0 0.0 2 4.0 2.041 0.153
Sever fatigue 0 0.0 3 6.0 3.093 0.079
Gastrointestinal symptoms 0 0.0 7 14.0 7.527 0.006
  1. aChi-square test